Disease Detection Articles

Articles

  • Can urinary biomarkers replace cystoscopy?

    Diagnosis and follow-up in patients with non-muscle invasive bladder cancer (NMIBC) rely on cystoscopy and urine cytology. The aim of this review paper is to give an update on urinary biomarkers and their diagnosis and surveillance potential.

    Published October 8, 2018
  • Molecular markers in disease detection and follow-up of patients with non-muscle invasive bladder cancer.

    Diagnosis and surveillance of non-muscle invasive bladder cancer (NMIBC) is mainly based on endoscopic bladder evaluation and urine cytology. Several assays for determining additional molecular markers (urine-, tissue- or blood-based) have been developed in recent years but have not been included in clinical guidelines so far.

    Published May 11, 2018